Nyamyc

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Nyamyc
Generic name: NYSTATIN
Manufacturer: Upsher-Smith Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 01b44f91-9b68-464a-9693-b5d3e793bf3c
SPL ID: 3984f88f-d61f-1fa9-e063-6394a90acb11
Version: 12
Effective date: 2025-07-09
Source export date: 2026-09-28
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:49:09

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 17 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	065183	derived:openfda.application_number
application number		ANDA065183	openfda.application_number
brand name		Nyamyc	openfda.brand_name
generic name		NYSTATIN	openfda.generic_name
manufacturer name		Upsher-Smith Laboratories, LLC	openfda.manufacturer_name
ndc	package	0832-0465-30	openfda.package_ndc
ndc	package	0832-0465-15	openfda.package_ndc
ndc	package	0832-0465-60	openfda.package_ndc
ndc	product	0832-0465	openfda.product_ndc
ndc11	package	00832046560	derived:openfda.package_ndc
ndc11	package	00832046515	derived:openfda.package_ndc
ndc11	package	00832046530	derived:openfda.package_ndc
rxcui		584414	openfda.rxcui
rxcui		646456	openfda.rxcui
spl id		3984f88f-d61f-1fa9-e063-6394a90acb11	id
spl set id		01b44f91-9b68-464a-9693-b5d3e793bf3c	set_id
unii		BDF1O1C72E	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The frequency of adverse events reported in patients using nystatin topical preparations is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. [see PRECAUTIONS: General ].

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.